Polyamine-modulated Factor-1 Methylation Predicts Bacillus Calmette-Guérin Response in Patients with High-grade Non–muscle-invasive Bladder Carcinoma

Treatment efficacy and tolerability of intravesical Bacillus Calmette-Guerin (BCG) - RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC)

BMC Urology ◽

10.1186/1471-2490-14-11 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 9

Author(s):

Naim B Farah ◽

Rami Ghanem ◽

Mahmoud Amr

Keyword(s):

Bladder Cancer ◽

Treatment Efficacy ◽

Invasive Bladder Cancer ◽

Low Grade ◽

High Grade ◽

Re: Intravesical rAd-IFNα/Syn3 for Patients with High-Grade, bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study

The Journal of Urology ◽

10.1016/j.juro.2018.09.011 ◽

2018 ◽

Vol 200 (6) ◽

pp. 1164-1164

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Randomized Study ◽

Invasive Bladder Cancer ◽

High Grade ◽

High-grade non-muscle-invasive bladder cancer: Is re-resection necessary in all patients before intravesical bacillus Calmette–Guérin treatment?

Scandinavian Journal of Urology ◽

10.3109/21681805.2013.769461 ◽

2013 ◽

Vol 47 (5) ◽

pp. 363-369 ◽

Cited By ~ 11

Author(s):

Sten Holmäng

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

High Grade ◽

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

European Urology ◽

10.1016/j.eururo.2020.04.066 ◽

2020 ◽

Vol 78 (5) ◽

pp. 690-698 ◽

Cited By ~ 5

Author(s):

Marc-Oliver Grimm ◽

Antoine G. van der Heijden ◽

Marc Colombel ◽

Tim Muilwijk ◽

Luis Martínez-Piñeiro ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Carcinoma ◽

European Association ◽

Standard Dose ◽

Phase Iii ◽

High Grade ◽

Phase Iii Clinical Trial ◽

Muscle Invasive ◽

European Association Of Urology

MP01-19 UTILIZATION PATTERNS OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR PATIENTS WITH HIGH-GRADE, NON-MUSCLE INVASIVE BLADDER CANCER

The Journal of Urology ◽

10.1016/j.juro.2016.02.1849 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Andrew Lenis ◽

Mark Litwin ◽

Christopher Saigal ◽

Nicholas Donin ◽

Julie Lai ◽

...

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

High Grade ◽

Utilization Patterns ◽

Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy

Transplant International ◽

10.1111/tri.12484 ◽

2014 ◽

Vol 28 (2) ◽

pp. 199-205 ◽

Cited By ~ 12

Author(s):

Thierry Roumeguère ◽

Nilufer Broeders ◽

Avinash Jayaswal ◽

Sandrine Rorive ◽

Thierry Quackels ◽

...

Keyword(s):

Renal Transplantation ◽

Bladder Carcinoma ◽

Aristolochic Acid ◽

Aristolochic Acid Nephropathy ◽

Muscle Invasive ◽

End Stage

Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin for High-grade Non–muscle-invasive Bladder Cancer

Urology ◽

10.1016/j.urology.2017.05.035 ◽

2017 ◽

Vol 107 ◽

pp. e3-e4 ◽

Cited By ~ 3

Author(s):

Neha Sihra ◽

Nonaka Diasuke ◽

Ramesh Thurairaja ◽

Muhammad Shamim Khan ◽

Sachin Malde

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

High Grade ◽

Renal Tuberculosis ◽

Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guérin (BCG) in Patients with Non–Muscle-Invasive Bladder Carcinoma

European Urology ◽

10.1016/j.eururo.2007.02.063 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1123-1130 ◽

Cited By ~ 82

Author(s):

Martin G. Friedrich ◽

Uwe Pichlmeier ◽

Hartwig Schwaibold ◽

Stefan Conrad ◽

Hartwig Huland

Keyword(s):

Adjuvant Chemotherapy ◽

Recurrence Rate ◽

Bladder Carcinoma ◽

Intravesical Chemotherapy ◽

Term Therapy ◽

Short Term ◽

Short Term Therapy ◽

1100 Adjuvant treatment of G2/high grade non-muscle invasive bladder cancer: Mytomicin or Bacillus Calmette-Guèrin?

European Urology Supplements ◽

10.1016/s1569-9056(14)61080-0 ◽

2014 ◽

Vol 13 (1) ◽

pp. e1100-e1100a

Author(s):

J. Palou ◽

O. Rodríguez Faba ◽

S. Skrobot ◽

J.A. Peña ◽

J.M. Gaya ◽

...

Keyword(s):

Bladder Cancer ◽

Adjuvant Treatment ◽

Invasive Bladder Cancer ◽

High Grade ◽

MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE

The Journal of Urology ◽

10.1097/ju.0000000000000959.01 ◽

2020 ◽

Vol 203 ◽

pp. e1121

Author(s):

Tristan Juvet* ◽

Christopher Wallis ◽

Lior Krimus ◽

Cynthia Kuk ◽

Annette Erlich ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Drug Administration ◽

High Grade ◽

Sequential Administration ◽

Bcg Failure ◽

Muscle Invasive ◽

Electromotive Drug Administration